JP2006517384A5 - - Google Patents

Download PDF

Info

Publication number
JP2006517384A5
JP2006517384A5 JP2004519896A JP2004519896A JP2006517384A5 JP 2006517384 A5 JP2006517384 A5 JP 2006517384A5 JP 2004519896 A JP2004519896 A JP 2004519896A JP 2004519896 A JP2004519896 A JP 2004519896A JP 2006517384 A5 JP2006517384 A5 JP 2006517384A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
cell
pro71042
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004519896A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006517384A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/021083 external-priority patent/WO2004004649A2/en
Publication of JP2006517384A publication Critical patent/JP2006517384A/ja
Publication of JP2006517384A5 publication Critical patent/JP2006517384A5/ja
Pending legal-status Critical Current

Links

JP2004519896A 2002-07-08 2003-07-08 免疫関連疾患の治療のための組成物と方法 Pending JP2006517384A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39448502P 2002-07-08 2002-07-08
PCT/US2003/021083 WO2004004649A2 (en) 2002-07-08 2003-07-08 Compositions and methods for the treatment of immune related diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009190172A Division JP2010029191A (ja) 2002-07-08 2009-08-19 免疫関連疾患の治療のための組成物と方法

Publications (2)

Publication Number Publication Date
JP2006517384A JP2006517384A (ja) 2006-07-27
JP2006517384A5 true JP2006517384A5 (https=) 2006-09-07

Family

ID=30115724

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2004519896A Pending JP2006517384A (ja) 2002-07-08 2003-07-08 免疫関連疾患の治療のための組成物と方法
JP2009190172A Pending JP2010029191A (ja) 2002-07-08 2009-08-19 免疫関連疾患の治療のための組成物と方法
JP2012208148A Withdrawn JP2013048621A (ja) 2002-07-08 2012-09-21 免疫関連疾患の治療のための組成物と方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2009190172A Pending JP2010029191A (ja) 2002-07-08 2009-08-19 免疫関連疾患の治療のための組成物と方法
JP2012208148A Withdrawn JP2013048621A (ja) 2002-07-08 2012-09-21 免疫関連疾患の治療のための組成物と方法

Country Status (6)

Country Link
US (3) US20040138114A1 (https=)
EP (3) EP2332956A1 (https=)
JP (3) JP2006517384A (https=)
AU (2) AU2003247806B2 (https=)
CA (1) CA2489588A1 (https=)
WO (1) WO2004004649A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1562587A4 (en) * 2002-09-11 2006-07-19 Genentech Inc NEW COMPOSITIONS AND METHOD FOR THE TREATMENT OF IMMUNOMOTICS
JP5405111B2 (ja) * 2005-09-26 2014-02-05 ウルリヒ ルース Tsh受容体及び新規tsh受容体キメラに対する自己免疫抗体検出方法
WO2011099583A1 (ja) 2010-02-12 2011-08-18 国立大学法人埼玉大学 立体選択的オレフィン重合用触媒及び立体選択的ポリオレフィンの製造方法
AU2013364043B2 (en) 2012-12-21 2018-01-04 Seagen Inc. Anti-NTB-A antibodies and related compositions and methods

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
NZ201705A (en) 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4943529A (en) 1982-05-19 1990-07-24 Gist-Brocades Nv Kluyveromyces as a host strain
AU2353384A (en) 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4675187A (en) 1983-05-16 1987-06-23 Bristol-Myers Company BBM-1675, a new antibiotic complex
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
AU3145184A (en) 1983-08-16 1985-02-21 Zymogenetics Inc. High expression of foreign genes in schizosaccharomyces pombe
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
DE3675588D1 (de) 1985-06-19 1990-12-20 Ajinomoto Kk Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
AU597574B2 (en) 1986-03-07 1990-06-07 Massachusetts Institute Of Technology Method for enhancing glycoprotein stability
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US4946783A (en) 1987-01-30 1990-08-07 President And Fellows Of Harvard College Periplasmic protease mutants of Escherichia coli
US5010182A (en) 1987-07-28 1991-04-23 Chiron Corporation DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
GB8724885D0 (en) 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
ATE105585T1 (de) 1987-12-21 1994-05-15 Univ Toledo Transformation von keimenden pflanzensamen mit hilfe von agrobacterium.
AU4005289A (en) 1988-08-25 1990-03-01 Smithkline Beecham Corporation Recombinant saccharomyces
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
FR2646437B1 (fr) 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
ATE144281T1 (de) 1989-04-28 1996-11-15 Rhein Biotech Proz & Prod Gmbh Hefezellen der gattung-schwanniomyces
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
ES2096590T3 (es) 1989-06-29 1997-03-16 Medarex Inc Reactivos biespecificos para la terapia del sida.
FR2649120B1 (fr) 1989-06-30 1994-01-28 Cayla Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
ATE300615T1 (de) 1990-08-29 2005-08-15 Genpharm Int Transgene mäuse fähig zur produktion heterologer antikörper
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
US5206161A (en) * 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B
EP0586505A1 (en) 1991-05-14 1994-03-16 Repligen Corporation Heteroconjugate antibodies for treatment of hiv infection
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
DE69232137T2 (de) 1991-11-25 2002-05-29 Enzon Inc Multivalente antigen-bindende proteine
MD1367C2 (ro) 1992-11-13 2000-11-30 Idec Pharmaceuticals Corporation Metode de tratament al limfomului celulelor B, anticorpi anti-CD20, hibridom.
PT616812E (pt) 1993-03-24 2000-04-28 Berlex Biosciences Combinacao de compostos anti-hormonais e moleculas de ligacao no tratamento do cancro
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
AU2582897A (en) 1996-03-15 1997-10-01 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation
US6579520B2 (en) * 1998-05-15 2003-06-17 Genentech, Inc. IL-17 related mammalian cytokine polypeptides (IL-17E)
US6482923B1 (en) * 1997-09-17 2002-11-19 Human Genome Sciences, Inc. Interleukin 17-like receptor protein
WO1999014240A1 (en) * 1997-09-17 1999-03-25 Human Genome Sciences, Inc. Interleukin-17 receptor-like protein
US6849719B2 (en) * 1997-09-17 2005-02-01 Human Genome Sciences, Inc. Antibody to an IL-17 receptor like protein
EP1054961A2 (en) * 1998-02-17 2000-11-29 Incyte Pharmaceuticals, Inc. Human short-chain tnf-receptor family protein
EP1074617A3 (en) * 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
JP2002191363A (ja) * 1999-07-29 2002-07-09 Herikkusu Kenkyusho:Kk 全長cDNA合成用プライマー、およびその用途
CA2311201A1 (en) * 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins
KR100325731B1 (ko) 1999-08-24 2002-03-06 류정열 차량 슬라이딩도어의 안전록 장치
AU1916101A (en) * 1999-11-12 2001-06-06 Human Genome Sciences, Inc. 19 human secreted proteins
US6372431B1 (en) * 1999-11-19 2002-04-16 Incyte Genomics, Inc. Mammalian toxicological response markers
EP1254270A4 (en) * 2000-02-03 2004-04-07 Nuvelo Inc METHOD AND MATERIALS IN CONNECTION WITH CUB DOMAIN POLYPEPTIDES AND POLYNUCLEOTIDS
WO2001075166A2 (en) * 2000-03-31 2001-10-11 Genentech, Inc. Compositions and methods for detecting and quantifying gene expression
EP2206720A1 (en) * 2000-04-12 2010-07-14 Human Genome Sciences, Inc. Albumin fusion proteins
CN1444652A (zh) * 2000-05-24 2003-09-24 先灵公司 哺乳动物受体蛋白;相关试剂和方法
DE102007013739B3 (de) 2007-03-22 2008-09-04 Voestalpine Stahl Gmbh Verfahren zum flexiblen Walzen von beschichteten Stahlbändern

Similar Documents

Publication Publication Date Title
Hu et al. Molecular and functional characterization of the p62 complex, an assembly of nuclear pore complex glycoproteins.
JP2006516094A5 (https=)
WO2018097951A1 (en) Anti-mage-a3/a6 antibodies
TW201831516A (zh) 抗gpc3抗體
KR900700606A (ko) Ig-cd4융합 단백질을 코드화하는 클론된 유전자 및 그의 이용
JP2012515551A5 (https=)
CN113549148A (zh) Hcv核心脂质结合结构域单克隆抗体
JP2004512824A5 (https=)
KR102792597B1 (ko) Ns1-결합 단백질
KR102671155B1 (ko) Ns1 단백질의 결합 단백질
CN110832326A (zh) 变态反应的抗原及其表位
CN111848750B (zh) 一种快速富集和检测2019-nCoV的方法及试剂盒
CN116640216A (zh) 抗cd19抗体的抗体、抗cd22抗体的抗体及其应用
CN110551213B (zh) 抗丝状病毒单克隆中和抗体及其制备方法和应用
WO2008119358A2 (en) Surface-located streptococcus pneumoniae polypeptides for use in vaccine compositions
CN102232087A (zh) 修饰的人igf-1/e肽的抗体
JP2010029191A5 (https=)
JP2006521810A5 (https=)
JP2006517384A5 (https=)
WO2022179535A1 (zh) 抗SARS-CoV-2核衣壳蛋白的单克隆抗体及其制备方法和用途
Singh et al. Sera of leprosy patients with type 2 reactions recognize selective sequences in Mycobacterium leprae recombinant LSR protein
JP2006515748A5 (https=)
Sato et al. Characterization of anti-P monoclonal antibodies directed against the ribosomal protein–RNA complex antigen and produced using Murphy Roths large autoimmune-prone mice
US5169940A (en) Nucleotide sequences of protein MTP40 of M. tuberculosis
WO2017107131A1 (zh) Tp重组抗原及其制备方法和应用